Cerebos Pacific Ltd (CERE.SI)
--SGD
--
-- (--)
$4.12
--
--
--
--
55,400
$4.16
$2.32
About
Overall
| Beta: | 0.61 |
| Market Cap (Mil.): | $1,306.52 |
| Shares Outstanding (Mil.): | 314.82 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| CERE.SI | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 16.85 | 477.06 | 123.80 |
| EPS (TTM): | -3.32 | -- | -- |
| ROI: | 23.50 | 1.79 | 4.49 |
| ROE: | 23.17 | 3.47 | 7.30 |
Obesity worries lift health food prospects in Asia
TAIPEI (Reuters) - It's the growing number of customers such as Bill Chung, who is on a diet after packing on 30 kilograms, that food companies hope to attract as they expand health food lines in Asia.
Obesity worries lift health food prospects in Asia
TAIPEI (Reuters) - It's the growing number of customers such as Bill Chung, who is on a diet after packing on 30 kilograms, that food companies hope to attract as they expand health food lines in Asia.
FEATURE-Obesity worries lift health food prospects in Asia
TAIPEI, July 8 (Reuters) - It's the growing number of customers such as Bill Chung, who is on a diet after packing on 30 kilograms, that food companies hope to attract as they expand health food lines in Asia.
Primary rejects Sigma bid for assets-paper
SYDNEY (Reuters) - A bid by Australia's Sigma Pharmaceuticals Ltd for newly-acquired assets being sold by Primary Health Care Ltd has been rejected, the Australian Financial Review said on Monday.
Primary rejects Sigma bid for assets-paper
SYDNEY, May 19 (Reuters) - A bid by Australia's Sigma Pharmaceuticals Ltd for newly-acquired assets being sold by Primary Health Care Ltd has been rejected, the Australian Financial Review said on Monday.
PRESS DIGEST-Australian Business News - May 19
Compiled for Reuters by Media Monitors. Reuters has not verified these stories and does not vouch for their accuracy. THE AUSTRALIAN FINANCIAL REVIEW (www.afr.com) -- Primary Health Care has left Sigma Pharmaceuticals off its shortlist of bidders for the consumer and pharmacy assets formerly owned by Symbion. However, Sigma's bidding partner, retailer Metcash , remains in the running for the pharmacy distribution business. Food group Cerebos <C





Earnings vs
Estimates